Drug Controller General of India Calls Industry Meeting On Fixed-Dose Combinations Ban
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - The head of India's Central Drug Control Administration has asked industry associations to discuss a ban on almost 300 fixed-dose drug combinations on June 10, according to a spokesman for the agency, which regulates the manufacture, sale and distribution of drugs
You may also be interested in...
Drug Makers, Indian Regulators Design Plan For Fixed-Dose Phase-out
Indian drug makers and government regulators have designed a formula for determining which of 294 fixed-dose combination dugs are to be phased out of the market. The Confederation of Indian Pharmaceutical Industry reached an agreement with the government to have the industry cease production and marketing of 11 drugs on the government's ban list. The CIPI then is to conduct a product-by-product examination of the drugs for safety and efficacy. (Click here for more
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).